Developing Solutions, Inc

dSPACE and Argus Cyber Security Join Forces to Introduce New Cyber Security Test Automation Capabilities, Shaping the Next Generation of Automotive Software Development

Retrieved on: 
Thursday, December 14, 2023

By integrating the Argus automation tool - Argus Fuzzing - with dSPACE's SCALEXIO Hardware-in-the-Loop (HIL) systems, dSPACE can now offer vehicle manufacturers and suppliers a continuous integration, delivery, and testing (CI/CD/CT) toolchain enhanced with cutting-edge cyber security testing capabilities from Argus.

Key Points: 
  • By integrating the Argus automation tool - Argus Fuzzing - with dSPACE's SCALEXIO Hardware-in-the-Loop (HIL) systems, dSPACE can now offer vehicle manufacturers and suppliers a continuous integration, delivery, and testing (CI/CD/CT) toolchain enhanced with cutting-edge cyber security testing capabilities from Argus.
  • As automotive systems grow in complexity, developers need to perform cyber security testing early and often to reduce the risks and costs of late-stage vulnerability discoveries.
  • Accordingly, vehicle manufacturers and suppliers are looking to incorporate cyber security testing in their CI/CD/CT pipelines and related workflows.
  • Leveraging Argus' expertise gained through decades of cyber security research allows automotive manufacturers and suppliers to conduct cyber security testing more efficiently and scalable.

Coming Off a Strong 2022, CentralReach Enters 2023 with a Focus on Helping Customers Unlock Positive Financial and Clinical Outcomes as They Navigate Current Economic Conditions and Staffing Challenges

Retrieved on: 
Tuesday, March 21, 2023

Total full-time employees grew 10% year over year, with almost 400 employees by year-end.

Key Points: 
  • Total full-time employees grew 10% year over year, with almost 400 employees by year-end.
  • Therapy sessions grew by 55% year over year, totalling over 20 million sessions for the year.
  • Clinical data points were up 40% year over year, expanding to a total of over 2.5 billion points.
  • This Autism and IDD Care Leadership Tour will be hosted in four states to start: New Jersey, California, Florida, and Texas.

MWC 2023: Huawei Enterprise BG Will Showcase Innovative Products and Solutions for a More Intelligent and Connected World

Retrieved on: 
Monday, February 27, 2023

BARCELONA, Spain, Feb. 27, 2023 /PRNewswire/ -- Huawei Enterprise BG — pursuing the mission to lead digital infrastructure construction, create new value for the industry — showcase innovative products and solutions at the Mobile World Congress (MWC) 2023.

Key Points: 
  • BARCELONA, Spain, Feb. 27, 2023 /PRNewswire/ -- Huawei Enterprise BG — pursuing the mission to lead digital infrastructure construction, create new value for the industry — showcase innovative products and solutions at the Mobile World Congress (MWC) 2023.
  • Huawei Enterprise BG has been deeply engaged in industry digital transformation, digital infrastructure innovation, and partner ecosystems.
  • During the exhibition, it will showcase star products and leading solutions for the government and enterprise markets.
  • In terms of public services, Huawei will release the Smart Classroom 2.0 solution, a shining new example of informatization for education.

MWC 2023: Huawei Enterprise BG Will Showcase Innovative Products and Solutions for a More Intelligent and Connected World

Retrieved on: 
Monday, February 27, 2023

BARCELONA, Spain, Feb. 27, 2023 /PRNewswire/ -- Huawei Enterprise BG — pursuing the mission to lead digital infrastructure construction, create new value for the industry — showcase innovative products and solutions at the Mobile World Congress (MWC) 2023.

Key Points: 
  • BARCELONA, Spain, Feb. 27, 2023 /PRNewswire/ -- Huawei Enterprise BG — pursuing the mission to lead digital infrastructure construction, create new value for the industry — showcase innovative products and solutions at the Mobile World Congress (MWC) 2023.
  • Huawei Enterprise BG has been deeply engaged in industry digital transformation, digital infrastructure innovation, and partner ecosystems.
  • During the exhibition, it will showcase star products and leading solutions for the government and enterprise markets.
  • In terms of public services, Huawei will release the Smart Classroom 2.0 solution, a shining new example of informatization for education.

Botanical Solution Inc. (BSI) ‘Finalist’ for “Best Industry Collaboration with Syngenta” in Crop Science Awards

Retrieved on: 
Wednesday, October 19, 2022

Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials for agricultural and pharmaceutical applications, has been named a Finalist in the Crop Science Award for Best Industry Collaboration with distribution partner Syngenta.

Key Points: 
  • Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials for agricultural and pharmaceutical applications, has been named a Finalist in the Crop Science Award for Best Industry Collaboration with distribution partner Syngenta.
  • View the full release here: https://www.businesswire.com/news/home/20221018006283/en/
    Syngenta's global team visits Botanical Solution Inc. (BSI ) R&D labs and production facilities in Santiago, Chile.
  • (Photo: Business Wire)
    In 2019, BSI launched an innovative botanical-based biofungicide extracted from a tree which grows in Chile known as the Quillaja saponaria.
  • Consequently, were happy and proud to share this 'Best Industry Collaboration' recognition with our Syngenta partners.

BRAINBox Solutions Announces New U.S. Patent Allowance, Strengthening Biomarker Portfolio for Multi-Modal Mild Traumatic Brain Injury Test

Retrieved on: 
Tuesday, October 4, 2022

RICHMOND, Va., Oct. 4, 2022 /PRNewswire/ -- BRAINBox Solutions, Inc announced today that the U.S. Patent & Trademark Office (PTO) issued a notice of allowance for a patent covering methods for detection of mild traumatic brain injury (mTBI), also known as concussion, using Brain Derived Neurotrophic Factor (BDNF). BDNF is an important component of the biomarker panel in the multi-modal diagnostic prognostic and prognostic solutions the company is developing for mTBI.

Key Points: 
  • "BRAINBox's test is the first to integrate blood biomarkers with functional testing for both the diagnosis and prognosis of mild TBI," said Donna Edmonds, BRAINBox Solutions' Chief Executive Officer.
  • "The new BDNF patent is an important addition to our broad, worldwide portfolio of patents covering biomarkers related to various aspects of diagnostic use.
  • The newly allowed patent is based on BRAINBox Solutions' discovery that a decrease in blood levels of BDNF alone are sensitive and specific in the detection of mild TBI.
  • BRAINBox Solutions is developing the first AI enabled, multi-modality approach for the diagnosis and prognosis of Mild Traumatic Brain Injury, commonly referred to as a concussion.

Foxit Announces Launch of AI-Based Smart Redact

Retrieved on: 
Tuesday, April 12, 2022

FREMONT, Calif., April 12, 2022 /PRNewswire/ -- Foxit, a leading provider of innovative PDF products and services, helping knowledge workers to increase their productivity and do more with documents, today announced the availability of Foxit Smart Redact, a new AI-powered tool providing document redaction. With the launch of Foxit Smart Redact, users now have an efficient and comprehensive tool that provides the ability to detect sensitive data within their PDF documents.

Key Points: 
  • With the launch of Foxit Smart Redact, users now have an efficient and comprehensive tool that provides the ability to detect sensitive data within their PDF documents.
  • Foxit Smart Redact helps users who want to redact sensitive information in PDF documents but need assistance in determining the exact words to redact in advance.
  • Key features of Foxit Smart Redact include:
    Foxit Smart Redact is fully integrated into Foxit PDF Editor as an optional plug-in.
  • "By leveraging artificial intelligence, Foxit Smart Redact dramatically improves the productivity of knowledge workers involved in redaction," said Frank Kettenstock, CMO of Foxit.

New Protocol Could Push the Limits of the Pharmaceutical Industry

Retrieved on: 
Tuesday, March 1, 2022

MONTRAL and LAVAL, QC, March 1, 2022 /CNW Telbec/ - Pharmaceutical compounds can behave differently in aqueous solution.

Key Points: 
  • MONTRAL and LAVAL, QC, March 1, 2022 /CNW Telbec/ - Pharmaceutical compounds can behave differently in aqueous solution.
  • Professor Steven LaPlante of the Institut national de la recherche scientifique (INRS) has developed a protocol to monitor the solution behavior of drugs.
  • "With this protocol, pharmaceutical industries could avoid working on a compound with undesirable activity in aqueous solution at the early lead identification stages.
  • This would avoid issues and downstream waste in productivity," says Professor LaPlante, who has many years of experience in the pharmaceutical industry.

Foxit PDF Editor Honored in G2's 2022 Best Software Awards for Top Office Product

Retrieved on: 
Tuesday, February 22, 2022

Foxit PDF Editor was selected based on the solution's focus on innovation, affordability and security.

Key Points: 
  • Foxit PDF Editor was selected based on the solution's focus on innovation, affordability and security.
  • "We are honored to be recognized by G2 as a leader in the Office Products and Top Global Seller categories," said Frank Kettenstock, Chief Marketing Officer at Foxit.
  • Foxit PDF Editor provides a cost-effective solution for business professionals to work securely with PDF documents and forms.
  • Foxit PDF Editor provides unmatched benefits and features to users, including:
    Integration with Foxit eSign to:
    To learn more about Foxit PDF Editor, please visit: https://www.foxit.com/pdf-editor/
    G2 is the world's largest and most trusted software marketplace, helping more than 60 million people every year make smarter software decisions based on authentic peer reviews.

Bone Solutions Inc. Receives FDA Clearance for Mg OSTEOREVIVE Spine Magnesium-Based Bone Void Filler

Retrieved on: 
Wednesday, February 2, 2022

Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX announced today that it has received 510(k) clearance from the FDA for Mg OSTEOREVIVE, a magnesium-based injectable and moldable bone void filler indicated for posterolateral spine fusion procedures.

Key Points: 
  • Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX announced today that it has received 510(k) clearance from the FDA for Mg OSTEOREVIVE, a magnesium-based injectable and moldable bone void filler indicated for posterolateral spine fusion procedures.
  • This FDA clearance is a key step in the development of Bone Solutions, stated BSI president and CEO, Drew Diaz.
  • Introducing Mg OSTEOREVIVE to the spine market is a further demonstration of our commitment to delivering superior magnesium-based orthopedic solutions to address market needs.
  • Mg OSTEOREVIVE is a registered trademark of Bone Solutions, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20220202005699/en/